2m 2m 2m 2m 2m 2m 2m
PULMONX (LUNG)
NASDAQ
$1.88+$0.03 (+1.62%)
Price as of Sep 11, 2026 7:30 PM EDT- $79.5MMarket Cap
- 8.82%1-Year Change
- Medical DevicesIndustry
PULMONX (LUNG)
$1.88+$0.03 (+1.62%)
LUNG | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.85 | ||
Change | $0.00 (0.00%) | ||
Open | $1.94 | ||
High | $2.00 | ||
Low | $1.81 | ||
Previous Close | $1.85 | ||
Volume | 204,925 | ||
30-Day Average Volume | 405,976 | ||
1-Week Change | -16.29% | ||
1-Month Change | -18.14% | ||
1-Year Change | 8.82% | ||
3-Year Change | -82.82% | ||
5-Year Change | -95.24% | ||
Fundamentals | |||
Shares Outstanding | 42.9M | ||
Total Assets | $114.7M | ||
Market Cap | $79.5M | ||
Enterprise Value | $61.1M | ||
Period: QTR TTM FY | |||
Revenue | $22.8M | ||
Net Income | -$10.1M | ||
Free Cash Flow | -$5.2M | ||
EBIT | -$9.7M | ||
EBITDA | -$9.5M | ||
Net Working Capital | $67.7M | ||
EPS | -$0.24 | ||
Enterprise Value/EBITDA | -6 | ||
Enterprise Value/Revenue | 3 | ||
P/B | 2 | ||
P/E | -8 | ||
PEG | -0 | ||
Price/Free Cash Flow | -15 | ||
Price/Operating Cash Flow | -15 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue